Cardisio is a company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases.
Cardisio has raised $421K in total funding. The most recent round was Grant. The last funding was announced in January 2023.
Cardisio's investors include LEA Partners, James Davidson, Shawn O'Neill, SBRI Healthcare.
Cardisio is headquartered in Frankfurt, Germany.
Cardisio is a company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases.
Cardisio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cardisio — Funding & Investors." VCBacked, January 17, 2023, https://www.vcbacked.co/company/cardisio. Accessed September 29, 2026.
VCBacked. (2023). Cardisio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/cardisio
{{cite web |title=Cardisio — Funding & Investors |url=https://www.vcbacked.co/company/cardisio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated